Ageing and endothelium-mediated vascular dysfunction: the role of the NADPH oxidases

The present study aimed to determine the isoform-specific role of the NADPH oxidases (NOX) in the endothelium-mediated vascular dysfunction associated with ageing. Endothelium-dependent [intraluminal flow- and acetylcholine (ACh)-induced] vasodilatation in human skeletal muscle feed arteries (SMFAs) of young (24 & PLUSMN; 1 years, n = 16), middle aged (45 & PLUSMN; 1 years, n = 18) and old (76 & PLUSMN; 2 years, n = 21) subjects was assessed in vitro with and without the inhibition of NOX1 (ML090), NOX2 (gp91) and NOX4 (plumbagin). To identify the role of nitric oxide (NO) bioavailability in these responses, NO synthase blockade (l-(NG)-monomethyl arginine citrate) was utilized. SMFA NOX1, NOX2 and NOX4 protein expression was determined by western blotting. Age related endothelium-dependent vasodilatory dysfunction was evident in response to flow (young: 69 & PLUSMN; 3; middle aged: 51 & PLUSMN; 3; old: 27 & PLUSMN; 3%, P < 0.05) and ACh (young: 89 & PLUSMN; 2; middle aged: 72 & PLUSMN; 3; old: 45 & PLUSMN; 4%, P < 0.05). NOX1 inhibition had no effect on SMFA vasodilatation, whereas NOX2 inhibition restored flow- and ACh-induced vasodilatation in the middle aged and the old SMFAs (middle aged + gp91: 69 & PLUSMN; 3; 86 & PLUSMN; 3, old + gp91: 65 & PLUSMN; 5; 83 & PLUSMN; 2%, P < 0.05) and NOX4 inhibition tended to restore these vasodilatory responses in these two groups, but neither achieved statistical significance (P & AP; 0.06). l-(NG)-monomethyl arginine citrate negated the restorative effects of NOX2 and NOX4 blockade. Only NOX2 and NOX4 protein expression was significantly greater in the two older groups and inversely related to vascular function (r = 0.48 to 0.93, P < 0.05). NOX2 and, to a lesser extent, NOX4 appear to play an important, probably NO-mediated, role in age-related endothelial dysfunction.